The table below shows Pulse Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$54.12M
-$36.34M
-$33.04M
-$47.01M
-$54.10M
-$35.37M
Capital expenditure
$315.00K
$125.00K
$121.00K
$401.00K
$437.00K
$441.00K
Investing cash flow
-$335.00K
-$125.00K
-$121.00K
-$401.00K
$7.56M
$10.04M
Dividends paid
-
-
-
-
PLSE operating cash flow (10-K history)
Pulse Biosciences, Inc. reported operating cash flow of -$54.12M for fiscal year 2025. That is down 48.9% from -$36.34M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$8.05M (FY 2016) to -$54.12M. Figures come from the company's audited annual reports as filed with the SEC.